 PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 28, 2021 GLOBE NEWSWIRE -- Adaptimmune Therapeutics plc Nasdaq:ADAP, a leader in cell therapy to treat cancer, will report financial results and provide a business update for the second quarter ended June 30, 2021, after the US markets close on Monday, August 9, 2021. Following the announcement, the Company will host a live teleconference and webcast at 4:30 p.m. EDT 9:30 p.m. BST that same day details below. 